19 years of historical data (2007–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Addus HomeCare Corporation trades at 18.5x earnings, 35% below its 5-year average of 28.6x, sitting at the 20th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.2x, the stock trades at a discount of 16%. On a free-cash-flow basis, the stock trades at 17.4x P/FCF, 23% below the 5-year average of 22.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.8B | $2.0B | $2.2B | $1.5B | $1.6B | $1.5B | $1.9B | $1.4B | $891M | $405M | $404M |
| Enterprise Value | $1.9B | $2.1B | $2.4B | $1.6B | $1.7B | $1.6B | $2.0B | $1.4B | $838M | $394M | $421M |
| P/E Ratio → | 18.55 | 20.61 | 29.63 | 24.24 | 35.03 | 33.28 | 56.29 | 54.93 | 51.04 | 29.74 | 33.70 |
| P/S Ratio | 1.27 | 1.39 | 1.89 | 1.43 | 1.69 | 1.74 | 2.44 | 2.14 | 1.72 | 0.95 | 1.01 |
| P/B Ratio | 1.64 | 1.83 | 2.24 | 2.14 | 2.54 | 2.62 | 3.60 | 2.91 | 3.23 | 2.31 | 2.54 |
| P/FCF | 17.36 | 19.09 | 19.74 | 14.73 | 16.63 | 43.11 | 18.21 | 187.24 | 31.99 | 8.24 | — |
| P/OCF | 16.16 | 17.77 | 18.71 | 13.49 | 15.32 | 38.04 | 17.08 | 115.25 | 26.83 | 7.67 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Addus HomeCare Corporation's enterprise value stands at 12.4x EBITDA, 31% below its 5-year average of 18.0x. The Healthcare sector median is 14.1x, placing the stock at a 12% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.48 | 2.04 | 1.53 | 1.80 | 1.85 | 2.57 | 2.09 | 1.62 | 0.93 | 1.05 |
| EV / EBITDA | 12.44 | 13.60 | 20.24 | 15.46 | 20.63 | 19.85 | 34.71 | 29.89 | 26.63 | 12.34 | 19.03 |
| EV / EBIT | 13.91 | 15.38 | 21.97 | 17.58 | 24.72 | 24.12 | 43.49 | 37.35 | 32.96 | 14.78 | 23.07 |
| EV / FCF | — | 20.31 | 21.31 | 15.81 | 17.64 | 45.83 | 19.14 | 183.14 | 30.08 | 8.02 | — |
Margins and return-on-capital ratios measuring operating efficiency
Addus HomeCare Corporation earns an operating margin of 9.7%. Operating margins have expanded from 8.6% to 9.7% over the past 3 years, signaling improving operational efficiency. ROE of 9.3% is modest. ROIC of 8.8% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.5% | 32.5% | 32.5% | 32.1% | 31.5% | 31.2% | 29.6% | 27.6% | 26.7% | 27.2% | 26.5% |
| Operating Margin | 9.7% | 9.7% | 8.9% | 8.6% | 7.2% | 7.6% | 5.8% | 5.4% | 4.4% | 5.9% | 3.9% |
| Net Profit Margin | 6.7% | 6.7% | 6.4% | 5.9% | 4.8% | 5.2% | 4.3% | 3.9% | 3.4% | 3.2% | 3.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.3% | 9.3% | 8.8% | 9.3% | 7.6% | 8.3% | 6.7% | 6.7% | 7.8% | 8.1% | 8.0% |
| ROA | 6.7% | 6.7% | 6.0% | 6.4% | 4.9% | 4.9% | 4.3% | 5.1% | 5.6% | 5.5% | 5.7% |
| ROIC | 8.8% | 8.8% | 7.9% | 8.8% | 7.4% | 7.7% | 6.3% | 7.8% | 8.9% | 11.1% | 7.3% |
| ROCE | 10.9% | 10.9% | 9.6% | 10.8% | 8.4% | 8.4% | 6.9% | 8.2% | 9.0% | 12.7% | 9.3% |
Solvency and debt-coverage ratios — lower is generally safer
Addus HomeCare Corporation carries a Debt/EBITDA ratio of 1.3x, which is manageable (57% below the sector average of 3.1x). Net debt stands at $127M ($209M total debt minus $82M cash). Interest coverage of 14.3x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.19 | 0.19 | 0.28 | 0.25 | 0.28 | 0.46 | 0.46 | 0.17 | 0.06 | 0.25 | 0.16 |
| Debt / EBITDA | 1.35 | 1.35 | 2.35 | 1.67 | 2.15 | 3.28 | 4.24 | 1.80 | 0.55 | 1.35 | 1.13 |
| Net Debt / Equity | — | 0.12 | 0.18 | 0.16 | 0.15 | 0.16 | 0.18 | -0.06 | -0.19 | -0.06 | 0.11 |
| Net Debt / EBITDA | 0.82 | 0.82 | 1.50 | 1.05 | 1.18 | 1.18 | 1.67 | -0.67 | -1.69 | -0.34 | 0.77 |
| Debt / FCF | — | 1.22 | 1.58 | 1.07 | 1.01 | 2.72 | 0.92 | -4.09 | -1.91 | -0.22 | — |
| Interest Coverage | 14.30 | 14.30 | 13.85 | 8.32 | 7.76 | 11.40 | 14.15 | 11.68 | 5.07 | 5.96 | 7.83 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.80x means Addus HomeCare Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.38x to 1.80x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.80 | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 | 3.08 | 2.86 | 2.98 | 2.64 |
| Quick Ratio | 1.80 | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 | 3.08 | 2.86 | 2.98 | 2.64 |
| Cash Ratio | 0.55 | 0.55 | 0.63 | 0.45 | 0.61 | 1.44 | 1.01 | 1.28 | 1.14 | 1.03 | 0.16 |
| Asset Turnover | — | 0.99 | 0.82 | 1.03 | 1.01 | 0.91 | 0.86 | 1.02 | 1.46 | 1.59 | 1.73 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 38.92 | 42.76 | 40.02 | 48.42 | 61.67 | 64.20 | 86.21 | 70.85 | 80.19 | 107.26 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Addus HomeCare Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 5.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.4% | 4.9% | 3.4% | 4.1% | 2.9% | 3.0% | 1.8% | 1.8% | 2.0% | 3.4% | 3.0% |
| FCF Yield | 5.8% | 5.2% | 5.1% | 6.8% | 6.0% | 2.3% | 5.5% | 0.5% | 3.1% | 12.1% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $18M | $17M | $16M | $16M | $16M | $16M | $14M | $13M | $12M | $12M |
Compare ADUS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $2B | 18.5 | 12.4 | 17.4 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 | |
| $2B | 27.2 | 22.1 | 11.4 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 | |
| $10B | 30.1 | 25.9 | 27.7 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 | |
| $2B | -23.9 | 10.0 | 9.7 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 | |
| $4B | -4902.7 | 76.6 | 32.8 | 12.4% | 0.4% | -0.5% | — | 7.5 | |
| $1B | 38.7 | 26.0 | 23.5 | — | 5.5% | 8.6% | 5.7% | 7.5 | |
| $326M | -3.5 | 16.5 | 6.8 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 | |
| $333B | 27.8 | 16.6 | 20.7 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 | |
| $110B | 62.5 | 13.0 | 14.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 | |
| $30B | 25.0 | 16.8 | 78.9 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 | |
| $27B | -4.1 | — | 6.3 | 12.2% | -3.9% | -28.7% | -21.6% | — | |
| Healthcare Median | — | 22.2 | 14.1 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 19 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Healthcare Services Group, Inc..
Start ComparisonQuick answers to the most common questions about buying ADUS stock.
Addus HomeCare Corporation's current P/E ratio is 18.5x. The historical average is 29.5x. This places it at the 20th percentile of its historical range.
Addus HomeCare Corporation's current EV/EBITDA is 12.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.6x.
Addus HomeCare Corporation's return on equity (ROE) is 9.3%. The historical average is 7.9%.
Based on historical data, Addus HomeCare Corporation is trading at a P/E of 18.5x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Addus HomeCare Corporation has 32.5% gross margin and 9.7% operating margin.
Addus HomeCare Corporation's Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.